XDR | 16 (55.2) |
Pre-XDR-TB | 13 (44.8) |
MDR+any one SLD | 10 (34.5) |
MDR+any two SLDs | 3 (10.3) |
MDR+any three SLDs | 12 (41.4) |
MDR+any four SLDs | 4 (13.8) |
Any drug resistance | |
Kanamycin | 12 (41.4) |
Capreomycin | 5 (17.2) |
Amikacin | 7 (24.1) |
Ofloxacin | 29 (100) |
Ethionamide | 13 (44.8) |
Clofazimine | 11 (37.9) |
Prothionamide | 7 (24.1) |
PAS | 8 (27.6) |
Cycloserine | 8 (27.6) |
Data are presented as n (%). XDR: extremely drug resistant; TB: tuberculosis; pre-XDR-TB: multidrug-resistant (MDR)-TB plus quinolone resistance without resistance against injectables; SLD: second-line drug resistance; PAS: para-aminosalicylic acid. #: drug-susceptibility testing against amoxycillin-clavulanic acid, linezolid, levofloxacin and moxifloxacin was not performed.